SPIRONOLACTONE tablet, film coated

País: Estados Unidos

Idioma: inglés

Fuente: NLM (National Library of Medicine)

Cómpralo ahora

Descargar Ficha técnica (SPC)
08-06-2010

Ingredientes activos:

SPIRONOLACTONE (UNII: 27O7W4T232) (SPIRONOLACTONE - UNII:27O7W4T232)

Disponible desde:

State of Florida DOH Central Pharmacy

Designación común internacional (DCI):

SPIRONOLACTONE

Composición:

SPIRONOLACTONE 25 mg

Vía de administración:

ORAL

tipo de receta:

PRESCRIPTION DRUG

indicaciones terapéuticas:

Spironolactone is indicated in the management of: Establishing the diagnosis of primary hyperaldosteronism by therapeutic trial. Short-term preoperative treatment of patients with primary hyperaldosteronism. Long-term maintenance therapy for patients with discrete aldosterone-producing adrenal adenomas who are judged to be poor operative risks or who decline surgery. Long-term maintenance therapy for patients with bilateral micro- or macronodular adrenal hyperplasia (idiopathic hyperaldosteronism). Congestive heart failure: For the management of edema and sodium retention when the patient is only partially responsive to, or is intolerant of, other therapeutic measures. Spironolactone is also indicated for patients with congestive heart failure taking digitalis when other therapies are considered inappropriate. Cirrhosis of the liver accompanied by edema and/or ascites: Aldosterone levels may be exceptionally high in this condition. Spironolactone is indicated for maintenance therapy together with bed rest a

Resumen del producto:

Spironolactone Tablets, USP are available as: 25 mg: white, round, film-coated tablets, debossed "5880" on one side and debossed "V" on the reverse side. 50 mg: white, oval, scored, film-coated tablets, debossed "58" bisect "81" on one side and debossed "V" on the reverse side. 100 mg: white, round, scored, film-coated tablets, debossed "58" bisect "82" on one side and debossed "V" on the reverse side. They are supplied by State of Florida DOH Central Pharmacy as follows:

Estado de Autorización:

Abbreviated New Drug Application

Ficha técnica

                                SPIRONOLACTONE - SPIRONOLACTONE TABLET, FILM COATED
STATE OF FLORIDA DOH CENTRAL PHARMACY
----------
SPIRONOLACTONE TABLETS, USP
25 MG, 50 MG, 100 MG
RX ONLY
WARNING
SPIRONOLACTONE HAS BEEN SHOWN TO BE A TUMORIGEN IN CHRONIC TOXICITY
STUDIES IN RATS (SEE
PRECAUTIONS). SPIRONOLACTONE SHOULD BE USED ONLY IN THOSE CONDITIONS
DESCRIBED UNDER
INDICATIONS AND USAGE. UNNECESSARY USE OF THIS DRUG SHOULD BE AVOIDED.
DESCRIPTION
Spironolactone Tablets, USP contain 25 mg, 50 mg, or 100 mg of the
aldosterone antagonist
spironolactone,
17-hydroxy-7α-mercapto-3-oxo-17α-pregn-4-ene-21-carboxylic acid
γ-lactone acetate,
which has the following structural formula:
Spironolactone is practically insoluble in water, soluble in alcohol,
and freely soluble in benzene and in
chloroform.
Inactive ingredients include calcium sulfate, hypromellose, magnesium
stearate, microcrystalline
cellulose, N & A mint flavor, polyethylene glycol, polysorbate 80,
povidone, pregelatinized starch,
sodium starch glycolate, talc, and titanium dioxide.
ACTIONS/CLINICAL PHARMACOLOGY
MECHANISM OF ACTION.
Spironolactone is a specific pharmacologic antagonist of aldosterone,
acting primarily through
competitive binding of receptors at the aldosterone-dependent
sodium-potassium exchange site in the
distal convoluted renal tubule. Spironolactone causes increased
amounts of sodium and water to be
excreted, while potassium is retained. Spironolactone acts both as a
diuretic and as an antihypertensive
drug by this mechanism. It may be given alone or with other diuretic
agents which act more proximally
in the renal tubule.
ALDOSTERONE ANTAGONIST ACTIVITY.
Increased levels of the mineralocorticoid, aldosterone, are present in
primary and secondary
hyperaldosteronism. Edematous states in which secondary aldosteronism
is usually involved include
congestive heart failure, hepatic cirrhosis, and the nephrotic
syndrome. By competing with aldosterone
for receptor sites, spironolactone provides effective therapy for the
edema and ascites in those
conditions. Spironolacto
                                
                                Leer el documento completo
                                
                            

Buscar alertas relacionadas con este producto